nivolumab,niraparib,ipilimumab
janssen,bms,gsk,takeda
['nivo', 'nivolumab', 'niraparib', 'ipilimumab', 'pancreatic']
 presents at #asco22 on #niraparib plus #nivolumab or #ipilimumab in patients with platinum-sensitive advanced #pancreaticcancer: s drs. domchek and vonderheide co-authored 
We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.